Viatrexx-Mesenchyme is a Intramuscular; Intravenous; Parenteral; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Viatrexx Bio Incorporated. The primary component is Bos Taurus Adrenal Gland; Sus Scrofa Adrenal Gland; Ascorbic Acid; Brain-derived Neurotrophic Factor Human; Prasterone; Malic Acid; Basic Fibroblast Growth Factor (human); Fucus Vesiculosus; Histidine; Hyaluronidase; Human Interleukin-6 (nonglycosylated); Lactic Acid; Sus Scrofa Lymph Vessel; Bos Taurus Lymph Vessel; Sus Scrofa Mesenchyme; Nadide; Sodium Diethyl Oxalacetate; Sodium Pyruvate; Sodium Sulfate; Phenylalanine; Prolactin; Rancid Beef; Thuja Occidentalis Leaf; Dodecahydroxycyclohexane Dihydrate; Tyrosine.
| Product ID | 73069-102_89209558-f60d-405c-a164-e41324db780c |
| NDC | 73069-102 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Viatrexx-Mesenchyme |
| Generic Name | Adrenal, Ascorbic Acid, Bdnf, Dhea, Malic Acid, Bfgf, Fucus Vesiculosus, Histidine, Hyaluronidase, Il-6, Lactic Acid, Lymph Node, Mesenchyme, Nad, Natrum Oxalaceticum, Natrum Pyruvicum, Natrum Sulphuricum, Phenylalanine, Amino Acid, Pyrogenium, Thuja Occidentalis, Trichinoyl, Tyrosine |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS |
| Marketing Start Date | 2019-03-29 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | VIATREXX BIO INCORPORATED |
| Substance Name | BOS TAURUS ADRENAL GLAND; SUS SCROFA ADRENAL GLAND; ASCORBIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; PRASTERONE; MALIC ACID; BASIC FIBROBLAST GROWTH FACTOR (HUMAN); FUCUS VESICULOSUS; HISTIDINE; HYALURONIDASE; HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED); LACTIC ACID; SUS SCROFA LYMPH VESSEL; BOS TAURUS LYMPH VESSEL; SUS SCROFA MESENCHYME; NADIDE; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SODIUM SULFATE; PHENYLALANINE; PROLACTIN; RANCID BEEF; THUJA OCCIDENTALIS LEAF; DODECAHYDROXYCYCLOHEXANE DIHYDRATE; TYROSINE |
| Active Ingredient Strength | 201 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL |
| Pharm Classes | Vitamin C [EPC],Ascorbic Acid [CS],Endoglycosidase [EPC],Glycoside Hydrolases [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-05-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Ingredient | Strength |
|---|---|
| BOS TAURUS ADRENAL GLAND | 201 [kp_C]/mL |
| SPL SET ID: | 93a04627-72a2-417c-9073-3695cc43ce8a |
| Manufacturer | |
| UNII | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 63776-102 | Viatrexx-Mesenchyme | Adrenal, Ascorbic Acid, BDNF, DHEA, Malic acid, bFGF, Fucus vesiculosus, Histidine, Hyaluronidase, IL-6, Lactic acid, Lymph node, Mesenchyme, NAD, Natrum oxalaceticum, Natrum pyruvicum, Natrum sulphuricum, Phenylalanine, Amino Acid, Pyrogenium, Thuja occidentalis, Trichinoyl, Tyrosine |
| 73069-102 | Viatrexx-Mesenchyme | Adrenal, Ascorbic Acid, BDNF, DHEA, Malic acid, bFGF, Fucus vesiculosus, Histidine, Hyaluronidase, IL-6, Lactic acid, Lymph node, Mesenchyme, NAD, Natrum oxalaceticum, Natrum pyruvicum, Natrum sulphuricum, Phenylalanine, Amino Acid, Pyrogenium, Thuja occidentalis, Trichinoyl, Tyrosine |